Gastric Ultrasound for Estimation of the Aspiration Risk Study

Overview

The purpose of this research study is to look at the effectiveness of current anesthesia guidelines regarding food and drink prior to surgery in patients who are likely to have food and drink remain in their stomach longer than might ordinarily be expected.

Full Title of Study: “Gastric Ultrasound for Estimation of the Aspiration Risk in High Aspiration-risk Surgical Patient Populations”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 14, 2025

Detailed Description

Examine the utility of ultrasound examination of the stomach in estimating aspiration risk in patient populations whose aspiration risk is currently poorly understood. Evaluate the applicability of current pre-surgical fasting guidelines in the same patient populations whose aspiration risk is poorly understood. Evaluate the residual gastric contents in patients presenting for upper GI endoscopy procedures who have adhered to pre-operative fasting guidelines. Evaluate the residual gastric contents in patients presenting for upper GI endoscopy procedures who have not adhered to pre-operative fasting guidelines. Only patients expected to have an oral-gastric tube placed during upper GI endoscopy procedure will be included. Both groups will be evaluated to learn if their residual gastric contents conform to currently-accepted standards for low aspiration risk.

Interventions

  • Behavioral: Interview questionnaire
    • Complete interview questionnaire regarding the composition and timing of their most recent food intake.
  • Procedure: Gastric ultrasound exam
    • Gastric ultrasound exam prior to upper GI endoscopy procedure.

Arms, Groups and Cohorts

  • Obeyed fasting guidelines
    • Scheduled GI endoscopy procedure with planned oral-gastric tube placed. Complete interview questionnaire. Gastric ultrasound exam prior to upper GI endoscopy procedure.
  • Did not obey fasting guidelines
    • Scheduled GI endoscopy procedure with planned oral-gastric tube placed. Complete interview questionnaire. Gastric ultrasound exam prior to upper GI endoscopy procedure.
  • Trauma – obeyed fasting guidelines
    • Scheduled GI endoscopy procedure with planned oral-gastric tube placed. Complete interview questionnaire. Gastric ultrasound exam prior to upper GI endoscopy procedure.
  • Trauma – did not obey fasting guidelines
    • Scheduled GI endoscopy procedure with planned oral-gastric tube placed. Complete interview questionnaire. Gastric ultrasound exam prior to upper GI endoscopy procedure.

Clinical Trial Outcome Measures

Primary Measures

  • Changes in gastric content volume between the four groups assessed by ultrasound examination
    • Time Frame: Up to 12 hours
    • Evaluate the residual gastric contents in patients presenting for upper GI endoscopy procedures to learn if their residual gastric contents conform to currently-accepted standards for low aspiration risk.

Participating in This Clinical Trial

Inclusion Criteria

  • Presenting for upper GI endoscopy procedures or surgical repair of a trauma- related injury – Expected to have an oral-gastric tube placed as part of scheduled procedure – Willing to undergo an ultrasound exam – Patients ≥ 18 years of age Exclusion Criteria:

  • Unwilling to undergo an ultrasound exam – Oral-gastric tube placement is not indicated – Oral-gastric tube placement is contraindicated – Pregnant patients and patients from defined vulnerable populations (ex. pediatric patients, mentally handicapped patients, prisoners, etc.) – Surgical trauma patients who are not expected to have an OG tube placed during surgery – Patients with history of gastric bypass surgery – Patients that are gastrostomy tube dependent

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 99 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Florida
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Cameron Smith, MD, PhD, Principal Investigator, University of Florida
  • Overall Contact(s)
    • Amy M. Gunnett, RN, CCRC, 352-273-8911, agunnett@anest.ufl.edu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.